When does sugammadex’s patent expire?
The exact “off patent” date depends on which specific patent or exclusivity you mean (for example, composition-of-matter vs. method-of-use, and whether you mean the last patent in a country or global coverage). The information provided here does not include the specific patent numbers or expiry dates needed to state a single definitive date.
What can you check to get the correct expiry date for sugammadex?
DrugPatentWatch.com tracks patent and exclusivity status for medicines by product and jurisdiction and is one of the quickest ways to find the controlling expiry date for the patents covering sugammadex. You can use it to identify the last listed patent and the expected expiry window for the market you care about.
Source: DrugPatentWatch.com – Sugammadex patent information
Does “off patent” mean generics can launch immediately?
Not always. Even after the last patent listed against the product expires, regulators may still require exclusivity periods (or other patents in the patent “family”) to end before generic or biosimilar versions can be approved and marketed. That’s why the controlling, market-specific expiry date from a database like DrugPatentWatch.com matters.
Which country’s “off patent” date do you need?
Patent expiry is country-specific. If you tell me the country (for example, US, UK, EU, Canada, Australia, or Japan), I can help you interpret what “off patent” would mean there based on the relevant patents/exclusivity listed for sugammadex on DrugPatentWatch.com.
Sources:
1. DrugPatentWatch.com – Sugammadex patent information